title: Are neuromodulating medications effective for the treatment of chronic neurogenic cough?
authors.affiliation: Department of Otolaryngology Head and Neck Surgery, University of Cincinnati, Cincinnati, Ohio, U.S.A.
authors.forename: John Paul
authors.initials: JP
authors.lastname: Giliberto
authors.affiliation: Division of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina, U.S.A.
authors.forename: Seth M
authors.initials: SM
authors.lastname: Cohen
authors.affiliation: Department of Otolaryngology-Head and Neck Surgery, University of Minnesota, Minneapolis, Minnesota, U.S.A.
authors.forename: Stephanie
authors.initials: S
authors.lastname: Misono
mesh_terms: D000588:Amines / Q000627:therapeutic use; D000639:Amitriptyline / Q000627:therapeutic use; D002908:Chronic Disease; D003371:Cough / Q000188:drug therapy* / Q000209:etiology; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D000077206:Gabapentin; D006801:Humans; D018377:Neurotransmitter Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017410:Practice Guidelines as Topic; D000069583:Pregabalin / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
chemical_list: D000588:Amines; D003509:Cyclohexanecarboxylic Acids; D018377:Neurotransmitter Agents; D000639:Amitriptyline; D000069583:Pregabalin; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin